Trial Profile

A Randomised, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 25 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs INI 2004 (Primary)
Indications Allergic rhinitis
Focus Adverse reactions; First in man
Sponsors Inimmune

Most Recent Events

30 Jul 2024 Status changed from recruiting to completed, according to an Inimmune media release.
15 May 2024 Topline results from Phase 1b Multiple Ascending Dose (MAD) study presented in an Inimmune media release.
07 Sep 2023 Planned number of patients changed to 68.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com